Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Tuesday, September 15, 2015 9:23:35 AM
bullish
## source: finance.yahoo.com
Mon, 14 Sep 2015 17:56:42 GMT ~ ITUS Corp. Earnings Q3, 2015
read full: http://www.capitalcube.com/blog/index.php/itus-corp-earnings-q3-2015/
*********************************************************
Tue, 01 Sep 2015 16:14:57 GMT ~ ITUS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
read full: http://biz.yahoo.com/e/150901/itus8-k.html
*********************************************************
Sat, 29 Aug 2015 17:04:08 GMT ~ ITUS CORP Financials
read full: http://finance.yahoo.com/q/is?s=itus
*********************************************************
Fri, 21 Aug 2015 00:09:56 GMT ~ 10-Q for CopyTele, Inc.
read full: http://www.companyspotlight.com/routers/headline/28541/10004/6564927?cp_code=YAH1&1440115796
*********************************************************
Tue, 18 Aug 2015 20:19:14 GMT ~ ITUS CORP Files SEC form 10-Q, Quarterly Report
read full: http://biz.yahoo.com/e/150818/itus10-q.html
*********************************************************
$ITUS charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$ITUS company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ITUS/company-info
Ticker: $ITUS
OTC Market Place: Not Available
CIK code: 0000715446
Company name: ITUS Corp.
Company website: http://www.ituscorp.com
Incorporated In: DE, USA
Business Description: ITUS funds, develops, acquires, and licenses emerging technologies. Our current areas of interest include High-Tech., Biotechnology, Life Sciences, and Informatics. Current licensing programs involve encrypted communications, and advanced materials. ITUS has an ongoing program to develop highly efficient, flat panel displays, based upon a proprietary technology utilizing carbon Nanotubes and phosphor-luminescence. Additional information is available at www.ITUScorp.com
$ITUS share structure
## source: otcmarkets.com
Market Value: $41,424,170 a/o Sep 14, 2015
Shares Outstanding: 8,720,878 a/o Aug 14, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
$ITUS extra dd links
Company name: ITUS Corp.
Company website: http://www.ituscorp.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ITUS+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ITUS+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ITUS+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ITUS/news - http://finance.yahoo.com/q/h?s=ITUS+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ITUS/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ITUS/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ITUS+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ITUS
DTCC (dtcc.com): http://search2.dtcc.com/?q=ITUS+Corp.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=ITUS+Corp.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=ITUS+Corp.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.ituscorp.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.ituscorp.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.ituscorp.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ITUS
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000715446&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ITUS/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ITUS/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ITUS&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ITUS
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ITUS/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ITUS+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ITUS+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ITUS
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ITUS
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ITUS+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ITUS/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ITUS+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ITUS.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ITUS
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ITUS/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ITUS/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ITUS
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ITUS
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ITUS:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ITUS
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ITUS
$ITUS DD Notes ~ http://www.ddnotesmaker.com/ITUS
Recent ANIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 12:35:37 PM
- Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines • PR Newswire (US) • 05/08/2024 12:25:00 PM
- Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja • PR Newswire (US) • 05/06/2024 12:05:00 PM
- Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024 • PR Newswire (US) • 04/30/2024 11:45:00 AM
- Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board • PR Newswire (US) • 04/18/2024 12:20:00 PM
- Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties • PR Newswire (US) • 03/14/2024 12:45:00 PM
- Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress • PR Newswire (US) • 03/11/2024 12:00:00 PM
- Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial • PR Newswire (US) • 02/12/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/08/2024 09:15:32 PM
- Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference • PR Newswire (US) • 01/29/2024 01:50:00 PM
- Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology • PR Newswire (US) • 01/23/2024 12:55:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 12:08:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 12:07:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 12:07:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 12:05:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 12:05:16 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/16/2024 10:29:43 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/16/2024 09:43:17 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/16/2024 09:30:49 PM
- Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024 • PR Newswire (US) • 01/10/2024 02:00:00 PM
- Anixa Biosciences to Present at Biotech Showcase 2024 • PR Newswire (US) • 12/14/2023 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 11:01:47 AM
- Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine • PR Newswire (US) • 12/06/2023 11:00:00 PM
- Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine • PR Newswire (US) • 12/06/2023 09:05:00 PM
- Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology • PR Newswire (US) • 11/27/2023 01:30:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM